欢迎来到《四川大学学报(医学版)》

COVID-19全球疫情及其应对策略留给我们的思索

陆权

陆权. COVID-19全球疫情及其应对策略留给我们的思索[J]. 四川大学学报(医学版), 2021, 52(6): 936-938. doi: 10.12182/20211160103
引用本文: 陆权. COVID-19全球疫情及其应对策略留给我们的思索[J]. 四川大学学报(医学版), 2021, 52(6): 936-938. doi: 10.12182/20211160103
LU Quan. Reflections on the Global Pandemic of COVID-19 and the Response Strategies[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION), 2021, 52(6): 936-938. doi: 10.12182/20211160103
Citation: LU Quan. Reflections on the Global Pandemic of COVID-19 and the Response Strategies[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION), 2021, 52(6): 936-938. doi: 10.12182/20211160103

COVID-19全球疫情及其应对策略留给我们的思索

doi: 10.12182/20211160103

Reflections on the Global Pandemic of COVID-19 and the Response Strategies

  • 摘要: 由新型冠状病毒(SARS-CoV-2)所引起的新型冠状病毒肺炎(COVID-19)仍在继续肆虐全球,给公共卫生体系带来巨大挑战,并威胁人类健康和生存。此次疫情留给我们太多思索:要关注呼吸道感染性疾病尤其人畜共患的新发呼吸道传染病;明确病毒病原的重要性,这关系到儿童肺炎的防治策略。由于COVID-19具有高传染性和病毒快速变异的特点,且缺乏特异性药物,故疫苗是目前最有效的预防手段,必须尽早建立全球免疫屏障。
  • [1] PETERSEN E, KOOPMANS M, GO U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis,2020,20(9): e238–e244. doi: 10.1016/S1473-3099(20)30484-9
    [2] JAIN S, WILLIAMS D J, ARNOLD S R, et al. Community-acquired pneumonia requiring hospitalization among U. S. children. N Engl J Med,2015,372(9): 835–845. doi: 10.1056/NEJMoa1405870
    [3] The Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: The PERCH multi-country case-control study. Lancet,2019,394(10200): 757–779. doi: 10.1016/S0140-6736(19)30721-4
    [4] 国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第八版). 国卫办医函〔2020〕680号. (2020-08-18)[2021-05-25]. http://www.nhc.gov.cn/xcs/zhengcwj/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a/files/a449a3e2e2c94d9a856d5faea2ff0f94.pdf.
    [5] BAYHAM J, FENICHEL E P. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: A modelling study. Lancet Public Health,2020,5(5): e271–e278[2021-06-01]. https://doi.org/10.1016/S2468-2667(20)30082-7. doi: 10.1016/S2468-2667(20)30082-7
    [6] HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell,2020,181(2): 271–280.e8. doi: 10.1016/j.cell.2020.02.052
    [7] SPINELLI M A, GLIDDEN D V, GENNATAS E D, et al. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. Lancet Infect Dis,2021,21(9): e296–e301. doi: 10.1016/S1473-3099(20)30982-8
    [8] WHO. Tracking SARS-CoV-2 variants. (2021-05-31) [2021-06-01]. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/COVID-19.
  • 加载中
计量
  • 文章访问数:  77
  • HTML全文浏览量:  19
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-04
  • 修回日期:  2021-08-29
  • 刊出日期:  2021-11-20

目录

    /

    返回文章
    返回